Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer

被引:13
作者
Algebaly, A. S. [1 ]
Suliman, R. S. [1 ]
Al-Qahtani, W. S. [1 ]
机构
[1] Princess Nourah Bint Abdulrahman Univ, Coll Sci, Biol Dept, Riyadh, Saudi Arabia
关键词
Breast cancer; Germline mutations; Riyadh; Heteroduplex DNA analysis; Sanger sequencing; BRCA1; BRCA2; Novel mutations; HETERODUPLEX ANALYSIS; MUTATIONS; WOMEN;
D O I
10.1007/s12094-020-02385-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background About 5-10% of incidences of breast cancers have been reported as a result of germline mutations of BRCA genes. However, the mutational spectrum of BRCA1 and BRCA2 genes among breast cancer Saudi women patients is inadequate at present. Therefore, the present study aimed to report the specific germinal mutation of BRCA1 and BRCA2 in the entire coding regions, to investigate the prevalence rate of BRCA1 & BRCA2 mutations among Saudi women and the effect of these mutations, both benign and malignant tumors. Methodology A total of 270 tissue samples of benign and malignant breast tumors were collected from Saudi women patients, Riyadh, Saudi Arabia. Examination of BRCA1 and BRCA2 germline mutations was performed using heteroduplex DNA analysis (HDA) or single-stranded conformation analysis (SSCA). 177 breast cancer women with malignant tumors and 93 with benign tumors were enrolled in the study. A total of 62 out of 177 breast cancer patients carried a BRCA1 or BRCA2 mutation (54 BRCA1 and 8 BRCA2). The analysis was done using the Sanger sequence assay. Results Point and frameshift mutations through the entire coding area of the two genes indicated that all the mutations were germline alterations and of early-onset breast cancers. The mean ages of diagnosed breast cancer women for BRCA1 and BRCA2 mutation carriers were 36.3 (+/- 3.5) and 37.9 (+/- 3.7) years, whereas that of benign control was 35(+/- 2.5) years. Conclusion Point and frameshift mutations across the entire coding region of BRCA1 and BRCA2 are responsible for many breast cancers cases.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 29 条
  • [1] Prevalence of BRCA1 and BRCA2 Mutations Among High-Risk Saudi Patients With Breast Cancer
    Abulkhair, Omalkhair
    Al Balwi, Mohammed
    Makram, Ola
    Alsubaie, Lamia
    Faris, Medhat
    Shehata, Hussam
    Hashim, Ahmed
    Arun, Banu
    Saadeddin, Ahmed
    Ibrahim, Ezzeldin
    [J]. JOURNAL OF GLOBAL ONCOLOGY, 2018, 4
  • [2] BRCA Testing Dichotomy in Saudi Arabia
    Abusanad, Atlal
    [J]. JOURNAL OF GLOBAL ONCOLOGY, 2019, 5
  • [3] A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens
    Alcaide, Miguel
    Cheung, Matthew
    Bushell, Kevin
    Arthur, Sarah E.
    Wong, Hui-Li
    Karasinska, Joanna
    Renouf, Daniel
    Schaeffer, David F.
    McNamara, Suzan
    du Tertre, Mathilde Couetoux
    Batist, Gerald
    Kennecke, Hagen F.
    Karsan, Aly
    Morin, Ryan D.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (02) : 214 - 227
  • [4] Almutlaq BA, 2017, J Mod Plast Surg, V7, P50
  • [5] ALmutlaq BA, 2018, AM J CLIN MED RES, V6, P10
  • [6] Almutlaq BA, 2017, J Cancer Policy, V12, P83, DOI 10.1016/j.jcpo.2017.03.004
  • [7] Alrashidi Ali Ghannam, 2017, Asian Pac J Cancer Prev, V18, P2755, DOI 10.22034/APJCP.2017.18.10.2755
  • [8] Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center
    Apessos, Angela
    Agiannitopoulos, Konstantinos
    Pepe, Georgia
    Tsaousis, Georgios N.
    Papadopoulou, Eirini
    Metaxa-Mariatou, Vasiliki
    Tsirigoti, Angeliki
    Efstathiadou, Chrysoula
    Markopoulos, Christos
    Xepapadakis, Grigorios
    Venizelos, Vasileios
    Tsiftsoglou, Aris
    Natsiopoulos, Loannis
    Nasioulas, George
    [J]. CANCER GENETICS, 2018, 220 : 1 - 12
  • [9] Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ
    Bayraktar, Soley
    Elsayegh, Nisreen
    Barrera, Angelica M. Gutierrez
    Lin, Heather
    Kuerer, Henry
    Tasbas, Tunc
    Muse, Kimberly I.
    Ready, Kaylene
    Litton, Jennifer
    Meric-Bernstam, Funda
    Hortobagyi, Gabriel N.
    Albarracin, Constance T.
    Arun, Banu
    [J]. CANCER, 2012, 118 (06) : 1515 - 1522
  • [10] BRCA1 and BRCA2:: From molecular genetics to clinical medicine
    Blackwood, MA
    Weber, BL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) : 1969 - 1977